7081 PHARMA | Malaysia

PHARMANIAGA BHD

RM 5.05 on: 2021-01-19

-2.32% Past 1-day return
-4.17% Past 5-day return

Covid19 Upside Pharmaceuticals


Price/Valuation Analysis
Current Price Status
  • Stock is Shooting to the Moon

    Stock is over-priced on the upper end by the market with the expectation of annual earning growth at 374.85% to match current price.

    Stock in booming mode can be traded very volatile, price can swing largely day-to-day. While having big upside potential, the downside risk can be huge if the stock is not meeting the market expectation.

  • Company is not in Profit
Fair Value
  • PHARMA current price is 274.07% above OneDelta estimated fair value.
  • The fair value is estimated via OneDelta proprietary model that updated daily basis based on stock fundamental and specific industry relative marco outlook. It can be assessed as stock potential upside range or the stock true value price in case of downside.

Relative Price Performance
  • Underperformed
    PHARMA past 5-day return lagged behind the Pharmaceuticals industry average return by 6.89%
  • Below 30-Day Average
    Current price RM5.05 is below 30-day average RM5.12 by 1.4%

Return (%) PHARMA Pharmaceuticals
1-Day-2.32% +0.09%
5-Day-4.17% +2.72%
30-Day-4.72% +1.58%
Bank Analyst Price Targets
HLG
HOLD
RM 5.70
KENANGA
SELL
RM 1.80
MIDF
HOLD
RM 4.74
Revenue & Earning Growth Analysis
  • Recent Weak Revenue Growth

    PHARMA posted a weaker revenue growth in the recent quarter than normal average.

  • Unstable Profit Growth

    PHARMA has been experiencing substantial ups and downs on profit growth.


Past Quarter Reports
Quarter Date Revenue (RM) (%) EPS (RM) (%)
2020-09-30 624,804k -3% 0.0055 -86%
2020-06-30 645,763k -21% 0.0382 -55%
2020-03-31 819,921k +15% 0.0857 0%
2019-12-31 715,683k -0% -0.6845 0%
2019-09-30 716,849k +19% 0.0018 -95%
Volume Trend Analysis
  • Recent Volume is Increasing

    Surge in trading volume tends to bring more price volatility in near term.

  • PHARMA recent daily traded volume is 109.09% higher than past month average.

Past 30-Day Past 5-Day
11k daily23k daily
Financials
Price History Chart
Past 30-day Average Price: RM5.12
Stock Fundamental Factors

Fundamental factor characteristics help us understand and expect how the stock price will behave in short and long term.

Stock Thematic Baskets

Usually the more the stock is included in popular themes, the more opportunity for price-driven momentum and better liquidity.

Stock Company Profile
PHARMANIAGA BHD

Pharmaniaga Bhd. is an investment holding company. It engages in the research & development, manufacturing of generic pharmaceutical products, sales & marketing as well as logistics and distribution of pharmaceutical products & medical equipment. The firm operates through the following segments: Logistics and Distribution, Manufacturing, and Indonesia. The Logistics and Distribution segment engages in distribution, trading and wholesaling of pharmaceutical and medical products as well as supply and installation of medical and hospital equipment in Malaysia. The Manufacturing segment manufactures pharmaceutical products in Malaysia. The Indonesia segment manufactures and distributes pharmaceutical and medical products in Indonesia. The company was founded on August 21, 1998 and is headquartered in Shah Alam, Malaysia.